OSR Health, Inc. (OSRH)
OTCMKTS · Delayed Price · Currency is USD
0.1700
+0.0025 (1.49%)
At close: Aug 27, 2026
OSR Health Employees
OSR Health had 22 employees as of December 31, 2025. The number of employees increased by 1 or 4.76% compared to the previous year.
Employees
22
Change (1Y)
1
Growth (1Y)
4.76%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
5.97M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 22 | 1 | 4.76% | 22 | 0 |
| Dec 31, 2024 | 21 | - | - | 19 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Adaptimmune Therapeutics | 272 |
| International Stem Cell | 33 |
| Reviva Pharmaceuticals Holdings | 14 |
| America Great Health | 5 |
| Hepion Pharmaceuticals | 2 |
OSR Health News
- 18 hours ago - Emerging Growth Research Issues Company-Sponsored Research Flash Report on OSR Health, Inc. - Accesswire
- 7 days ago - OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission - Accesswire
- 8 days ago - OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal - Accesswire
- 9 days ago - OSR Health Sees Global Shareholder Momentum at Critical Inflection Point - Accesswire
- 17 days ago - OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development - Accesswire
- 20 days ago - OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program - Accesswire
- 25 days ago - Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform - Accesswire
- 27 days ago - OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment - Accesswire